http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105213350-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 |
filingDate | 2015-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105213350-B |
titleOfInvention | Ditropan XL spansule and preparation method thereof |
abstract | The invention discloses a kind of ditropan XL spansule and preparation method thereof, ditropan XL spansule is composed of the following components, count by weight percentage, 6.8% ditropan XL, 86.8% sugar-pill, 1.3% hydroxypropyl methylcellulose, 0.3% 35% dimethicone emulsion, 3.7% Aquacoat, 0.8% dibutyl sebacate, 0.3% talcum powder.The present invention can keep effective blood concentration in vivo, no peak valley phenomenon, relatively reduce due to blood concentration it is excessively high caused by side effect, while reduce again due to blood concentration it is too low caused by without therapeutic effect;Reduce daily medicining times, improves patient's Compliance. |
priorityDate | 2015-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.